Article
Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis.
Molecular biology reports - 1 May 2013
Hussien Yousry Mostafa, Shehata Amal, Karam Rehab A, Alzahrani Saad S, Magdy Hanem, El-Shafey Abeer M
Abstract excerpt
1α,25-Dihydroxyvitamin D3 upregulates the expression of the receptor activator of nuclear factor kB ligand (RANKL), and downregulates osteoprotegerin (OPG) expression. We tested the effects of polymorphisms in the vitamin D receptor gene (VDR), and OPG gene in rheumatoid arthritis (RA) patients and healthy controls and their relationship to bone mineral density (BMD) and development of osteoporosis. Three hundred...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
